Equities

Poltreg SA

PTG:WSE

Poltreg SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (PLN)54.60
  • Today's Change0.00 / 0.00%
  • Shares traded608.00
  • 1 Year change-10.78%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6690104
Total Receivables, Net5.599.332.02
Total Inventory0.420.080
Prepaid expenses------
Other current assets, total------
Total current assets7299106
Property, plant & equipment, net54232.08
Goodwill, net------
Intangibles, net0.901.001.10
Long term investments------
Note receivable - long term0.330.06--
Other long term assets------
Total assets127123109
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt00.010.02
Current portion long-term debt/capital leases0.390.030.12
Other current liabilities, total9.665.644.61
Total current liabilities18145.68
Total long term debt7.807.860.04
Total debt8.197.900.18
Deferred income tax------
Minority interest------
Other liabilities, total130.630.40
Total liabilities40226.12
SHAREHOLDERS EQUITY
Common stock0.470.470.47
Additional paid-in capital------
Retained earnings (accumulated deficit)87101103
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity88101103
Total liabilities & shareholders' equity127123109
Total common shares outstanding4.664.664.66
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.